FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 67 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $84,993 | -19.1% | 29,822 | +39.6% | 0.00% | 0.0% |
| Q2 2022 | $105,000 | -14.6% | 21,356 | +81.4% | 0.00% | -50.0% |
| Q2 2021 | $123,000 | -39.1% | 11,773 | -31.3% | 0.01% | -20.0% |
| Q1 2021 | $202,000 | -12.9% | 17,144 | -13.5% | 0.01% | 0.0% |
| Q4 2020 | $232,000 | +45.9% | 19,811 | -1.5% | 0.01% | +42.9% |
| Q3 2020 | $159,000 | – | 20,105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |